Company intelligence / Profile preview

AICS

Ownership: Private
Development stage: Other

Overview

AICS delivers next-generation digital health platforms using hybrid cloud technology, modular microservices, and standardized medical data models to streamline integration and accelerate innovation in healthcare settings. No clinical trial results as it does not develop drugs.

Therapeutic areas: Other
Modalities: None (AICS provides digital health platforms and AI solutions; it does not develop therapeutic modalities such as small molecules or biologics)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Not specified in the search results. Likely partners with hospitals/medical centers for deployments.

Beyond the preview

Go deeper on AICS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AICS.

Explore the full profile